Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

121.44B

Market cap121.44B

Price-Earnings ratio

16.72

Price-Earnings ratio16.72

Dividend yield

4.20%

Dividend yield4.20%

Average volume

9.09M

Average volume9.09M

High today

$60.25

High today$60.25

Low today

$59.25

Low today$59.25

Open price

$60.01

Open price$60.01

Volume

6.49M

Volume6.49M

52 Week high

$62.89

52 Week high$62.89

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $59.25, giving the company a market capitalization of 121.44B. It carries a P/E multiple of 16.72 and pays a dividend yield of 4.2%.

During the trading session on 2026-05-22, Bristol-Myers Squibb(BMY) shares reached a daily high of $60.25 and a low of $59.25. At a current price of $59.25, the stock is 0.0% higher than the low and still -1.7% under the high.

Trading activity shows a volume of 6.49M, compared to an average daily volume of 9.09M.

The stock's 52-week range extends from a low of $42.52 to a high of $62.89.

BMY News

Seeking Alpha 4h

Bristol-Myers Squibb snaps six straight sessions of gains

BMY shares snapped six straight sessions of gains as the stock closed 0.15% lower at $59.46 on Friday. The biopharmaceutical company gained about 5% in the pre...

Simply Wall St 9h

Bristol Myers Squibb AI Deal With Anthropic And What It Means For BMY

Bristol Myers Squibb (NYSE:BMY) has entered an enterprise-wide AI partnership with Anthropic to deploy Claude across its global workforce. The rollout is desig...

Simply Wall St 2d

A Look At Bristol Myers Squibb Valuation After Recent Share Price Strength And Mixed Earnings Figures

Advertisement Stock performance snapshot Bristol-Myers Squibb (BMY) has drawn fresh attention after a solid year-to-date total return of about 9.5%, alongside...

Analyst ratings

60%

of 30 ratings

Buy

36.7%

Hold

60%

Sell

3.3%

More BMY News

Benzinga 2d

Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery

The collaboration aims to enhance the discovery and development of new medicines, leveraging Anthropic’s advanced AI capabilities to connect over 30,000 employe...

TipRanks 3d

Bristol-Myers Squibb’s REACH Study in China: What Real-World Luspatercept Data Could Mean for BMY Investors

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.